Literature DB >> 12820416

Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy.

S van Ruth1, V J Verwaal, A A M Hart, G W van Slooten, F A N Zoetmulder.   

Abstract

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) with mitomycin C has been applied following cytoreductive surgery for various peritoneal surface malignancies. The aim of this study was to evaluate heat penetration in the abdomen during 10 HIPEC procedures.
MATERIALS AND METHODS: Temperature measurements were taken at 5 levels through the abdominal wall. Core temperature and room temperature were also measured. The relationships between the temperature gradient and room or core temperature were studied.
RESULTS: At the start of perfusion, the temperature was estimated on average to be 40.6 degrees C at the first level, then it decreased by 1.7 degrees C (SD 1.0 degree C, p = 0.0001) in the first mm. In outward direction, it decreases by a further 1.5 degrees C per cm (SD 0.3 degree C/cm, p < 0.0001). The core temperature influenced the temperature gradient; the room temperature was not found to be a significant factor. At the end of perfusion, the temperature is estimated on average to be 40.1 degrees C at the first level, then it decreased by 0.8 degree C (SD 0.7 degree C, p = 0.011) in the first mm. In an outward direction, it decreased by a further 1.7 degrees C per cm (SD 0.4 degree C/cm, p = 0.0001). No evidence of an association between the temperature gradient and the room temperature or the core temperature was observed.
CONCLUSION: Hyperthermia used during HIPEC procedures has a limited penetration depth. The slope in temperature seems to be related to the core temperature.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12820416

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei).

Authors:  P Barrios; F Losa; S Gonzalez-Moreno; A Rojo; A Gómez-Portilla; P Bretcha-Boix; I Ramos; J Torres-Melero; R Salazar; M Benavides; T Massuti; E Aranda
Journal:  Clin Transl Oncol       Date:  2015-10-21       Impact factor: 3.405

Review 2.  Cytoreductive surgery and intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis from colorectal origin.

Authors:  F Losa; P Barrios; R Salazar; J Torres-Melero; M Benavides; T Massuti; I Ramos; E Aranda
Journal:  Clin Transl Oncol       Date:  2013-06-06       Impact factor: 3.405

3.  Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours.

Authors:  Joshua Lansom; Nayef Alzahrani; Winston Liauw; David L Morris
Journal:  Indian J Surg Oncol       Date:  2015-10-24

4.  Population pharmacokinetics and pharmacodynamics of mitomycin during intraoperative hyperthermic intraperitoneal chemotherapy.

Authors:  Serge van Ruth; Ron A A Mathôt; Rolf W Sparidans; Jos H Beijnen; Vic J Verwaal; Frans A N Zoetmulder
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

5.  Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.

Authors:  Joerg O W Pelz; J Doerfer; A Dimmler; W Hohenberger; T Meyer
Journal:  BMC Cancer       Date:  2006-06-22       Impact factor: 4.430

6.  A new survival model for hyperthermic intraperitoneal chemotherapy (HIPEC) in tumor-bearing rats in the treatment of peritoneal carcinomatosis.

Authors:  Joerg O W Pelz; Joerg Doerfer; Werner Hohenberger; Thomas Meyer
Journal:  BMC Cancer       Date:  2005-05-30       Impact factor: 4.430

7.  Nanoparticle-induced intraperitoneal hyperthermia and targeted photoablation in treating ovarian cancer.

Authors:  Chao-Chih Wu; Yuh-Cheng Yang; Yun-Ting Hsu; T-C Wu; Chien-Fu Hung; Jung-Tang Huang; Chih-Long Chang
Journal:  Oncotarget       Date:  2015-09-29

Review 8.  Principles and Innovations in Peritoneal Surface Malignancy Treatment.

Authors:  Kelly M MacArthur; Michael B Nicholl
Journal:  World J Oncol       Date:  2013-07-15

9.  A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function.

Authors:  Jinning Ye; Liuhua Chen; Jidong Zuo; Jianjun Peng; Chuangqi Chen; Shirong Cai; Wu Song; Yulong He; Yujie Yuan
Journal:  Cancer Biol Ther       Date:  2020-06-17       Impact factor: 4.742

10.  Intra-peritoneal hyperthermia combining α-galactosylceramide in the treatment of ovarian cancer.

Authors:  Chao-Chih Wu; Yin-Ting Chuang; Yun-Ting Hsu; Jung-Tang Huang; T-C Wu; Chien-Fu Hung; Yuh-Cheng Yang; Chih-Long Chang
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.